Covid19 Vaccine
-
EU court lambasts European Commission for failing to provide enough info on COVID-19 vaccine deals
World | July 17, 2024 14:14 ISTThe European Commission was tasked with organising the joint procurement of vaccines during the pandemic and leading negotiations with manufacturers. It refused to grant complete access to COVID-19 vaccine contracts worth $2.9 million to a group of EU lawmakers.
-
Another COVID-19 wave in Singapore, masks advised after 25,900 cases recorded in six days
World | May 18, 2024 16:25 ISTSingapore's health minister Ong Ye Kung said that over 25,900 cases were recorded between May 5 and May 11, more than 13,700 detected the previous week. He advised people to start wearing masks again and those at greater risk of disease to get vaccinated.
-
AstraZeneca announces global withdrawal of COVID-19 vaccine, cites 'commercial reasons'
Health | May 08, 2024 9:10 ISTAstraZeneca has begun the global withdrawal of its COVID-19 vaccine, Vaxzevria. This decision comes amid a surplus of more advanced vaccines targeting emerging variants of the virus.
-
Gujarat Congress calls for compensation over Covishield deaths; BJP denies vaccine link to heart att
Gujarat | May 01, 2024 23:11 ISTThe Gujarat Congress has urged for compensation for families affected by alleged Covishield-related deaths, citing neglect of WHO guidelines by the BJP-led central government. BJP-affiliated doctors deny a direct link between the vaccine and adverse events.
-
mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims
Health | January 10, 2023 13:12 ISTA US-based researcher mentioned that the US Food and Drug Administration (FDA) published study surveillance data finds the Pfizer Covid vaccine increases the risk of lung blood clots by 50 per cent.
-
Aaj Ki Baat: Covid nasal vaccine to be available soon, know the cost & everything| Coronavirus India
Aaj Ki Baat | December 28, 2022 0:03 ISTIn the midst of increasing corona cases in the country, the prices of the nasal vaccine given through the nose have been announced today. A dose of nasal vaccine will be given in government hospitals for Rs.325, while it will cost Rs.800 in private hospitals.
-
Milestone! India crosses 2 billion Covid-19 vaccination mark in 18 months
India | July 17, 2022 13:03 ISTCovid-19 vaccines in India: The data showed that 82 per cent of adolescents aged 15 to 18 years have also been vaccinated with the first dose since the vaccination for this age group began on January 3 while 68 per cent have got both the first and second dose.
-
Germany recognises Bharat Biotech's Covaxin for travel from June 1
India | May 26, 2022 12:07 ISTThe DCGI in April also granted an emergency use authorisation (EUA) to Covaxin for the age group of 6-12 years.
-
Covid vaccines for kids under 5: Pfizer says 3 shots '80% effective in preventing virus'
World | May 23, 2022 23:20 ISTPfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
-
As Covid cases rise, Delhi government makes booster doses free for 18-59 age group
India | April 22, 2022 10:23 ISTThe Central government had rolled out precautionary doses of Covid-19 vaccine for all adults in private hospitals on April 10.
-
China's zero Covid tolerance strategy fails! Vaccine efficacy under scanner as record cases surface
World | April 13, 2022 16:55 ISTChina has always been notorious about revealing the actual data of new Covid cases, deaths to the world. Most of the people in China have been given the 'Made in China' vaccine like Sinopharm but this hasn't been that effective compared to other vaccines.
-
Pvt hospitals can charge up to Rs 150 as service charge for Covid-19 precaution dose: Centre
India | April 09, 2022 16:30 ISTThe Centre announced on Friday that the precautionary dose of Covid vaccines will be available to everyone aged above 18 years at the private vaccination centers from April 10.
-
Covishield, Covaxin prices slashed to Rs 225 per dose ahead of booster shots drive
India | April 09, 2022 20:44 ISTSerum Institute of India's Covid-19 vaccine Covishield was earlier priced at Rs. 600. Bharat Biotech's Covaxin was priced at Rs 1200.
-
Bharat Biotech to soon rectify issues raised by WHO on Covaxin, say sources
India | April 05, 2022 6:58 ISTRecently, in a statement on WHO's suspension of Covaxin, Bharat Biotech said, "For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine."
-
Bharat Biotech says upgrading Covaxin facilities as WHO suspends vaccine supplies
India | April 04, 2022 10:10 ISTEarlier on Sunday, Bharat Biotech had said it had nothing else to add to an earlier statement where it said it is working on further improvements and upgrades to ensure that the production of Covaxin continues to meet ever increasing global regulatory requirements.
-
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension
India | April 03, 2022 9:48 ISTThe vaccine manufacturer has further said that the company is slowing down the production of Covaxin for facility optimization.
-
In a much better position to fight pandemic, says PM Modi as vaccination for 12-14 age group begins
India | March 16, 2022 11:04 ISTThe inoculation of children in the age group of 12 to 14 years against COVID-19 started on Wednesday with Corbevax vaccine.
-
Canada authorises first plant-based COVID-19 vaccine
World | February 25, 2022 15:11 ISTThe decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 - although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.
-
Covaxin to be evaluated as COVID-19 vaccine candidate in US, says Bharat Biotech
India | February 19, 2022 21:11 ISTCovaxin has already been granted Emergency Use Listing (EUL) in 13 countries.
-
India's first homegrown mRNA vaccine to be tested amid Omicron spike: Official sources
India | January 17, 2022 14:43 ISTmRNA vaccines belong to the category of nucleic acid vaccines, which use genetic material from disease-causing virus or pathogen to trigger an immune response against it within the body.
Top News
-
India hits back at NATO chief Mark Rutte's Russia trade warning: 'No double standards'
-
Air India crash: AAIB reacts to global media reporting, terms it 'irresponsible' and 'selective'
-
Caught on cam: Criminal on parole shot dead inside ICU by armed attackers in Patna's Paras Hospital
-
Highest strike rates for India in Test, minimum 1000 balls
Latest News
-
Cab chaos to worsen in Mumbai? Ola, Uber drivers gear up for major protest at Azad Maidan on Friday
-
Litton Das warns of tough challenge ahead of Pakistan T20I Series
-
'West Bengal suffering due to TMC misrule': PM Modi jabs at Mamata government ahead of visit
-
Aasif Khan reveals he didn’t suffer a heart attack, know real reason behind actor’s hospitalisation
-
Made-in-India iPhones a hit: Apple sets new record in first half of 2025
Trending
-
Man performs Bhangra on London Underground escalator, commuters record video | Watch
-
Prada team visits Kolhapur, engages with local artisans on footwear craftsmanship: Video
-
Video of Indonesian boy dancing on racing boat goes viral, internet says 'legendary aura farming'
-
Man's imitation of Donald Trump if he visited Taj Mahal has the internet in splits | WATCH
-
Couple shocked after 'eye doctor' advices against marriage, kids; says 'out of line, unscientific'